Back to search
FDAFDA · Food and drugs·Recall number D-0654-2020

Bull Platinum 30000 Capsules, 1000 mg, in orange, white, yellow background with silver text, packaged in 2, 4 and 10 count blister cards, Motto International, Dallas, TX

Published January 22, 2020 · Recall initiated: December 17, 2019

Summary

FDA records drug Class I recall D-0654-2020, published January 22, 2020 and initiated December 17, 2019. Recalling firm: Motto International Corp; Status: Terminated; Reported quantity: 8 boxes; Lot: All lots remaining within expiry. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Motto International Corp
Distributor
TX
Lot
All lots remaining within expiry.
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Bull Platinum 30000 Capsules, 1000 mg, in orange, white, yellow background with silver text, packaged in 2, 4 and 10 count blister cards, Motto International, Dallas, TX recalled?

Yes. FDA published recall D-0654-2020 on January 22, 2020. Reported hazard: Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil

What should I do if I have this product?

Voluntary: Firm initiated · Press Release